Renewal of Declaration Regarding Emergency Use of Doxycycline Hyclate Tablets Accompanied by Emergency Use Information, 61489-61490 [2010-24840]

Download as PDF Federal Register / Vol. 75, No. 192 / Tuesday, October 5, 2010 / Notices Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than October 29, 2010. A. Federal Reserve Bank of Atlanta (Clifford Stanford, Vice President) 1000 Peachtree Street, N.E., Atlanta, Georgia 30309: 1. PFGBI, LLC, McDonough, Georgia; to become a bank holding company by acquiring approximately 50.8 percent of the outstanding voting shares of Montgomery County Bankshares, Inc., and its subsidary, Montgomery County Bank & Trust, both of Ailey, Georgia. Board of Governors of the Federal Reserve System, September 30, 2010. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 2010–24901 Filed 10–4–10; 8:45 am] BILLING CODE 6210–01–S mstockstill on DSKH9S0YB1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Minority Health Office of Minority Health, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. AGENCY: VerDate Mar<15>2010 18:36 Oct 04, 2010 Jkt 223001 ACTION: Notice of meeting. As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the Advisory Committee on Minority Health (ACMH) will hold a meeting. This meeting is open to the public. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should e-mail acmh@osophs.dhhs.gov. DATES: The meeting will be held on Monday, November 15, 2010 from 9 a.m. to 5 p.m. and Tuesday, November 16, 2010 from 9 a.m. to 1 p.m. ADDRESSES: The meeting will be held at the Doubletree Hotel, 1515 Rhode Island Ave., NW., Washington, DC 20005. FOR FURTHER INFORMATION CONTACT: Ms. Monica A. Baltimore, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852. Phone: 240– 453–2882, Fax: 240–453–2883. SUPPLEMENTARY INFORMATION: In accordance with Public Law 105–392, the ACMH was established to provide advice to the Deputy Assistant Secretary for Minority Health in improving the health of each racial and ethnic minority group and on the development of goals and specific program activities of the Office of Minority Health. Topics to be discussed during this meeting will include increasing the health care workforce and strategies to improve the health of racial and ethnic minority populations through the development of health policies and programs that will help eliminate health disparities, as well as other related issues. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person at least fourteen (14) business days prior to the meeting. Members of the public will have an opportunity to provide comments at the meeting. Public comments will be limited to three minutes per speaker. Individuals who would like to submit written statements should mail or fax their comments to the Office of Minority Health at least seven (7) business days prior to the meeting. Any members of the public who wish to have printed material distributed to ACMH committee members should submit their materials to the Executive Secretary, ACMH, Tower Building, 1101 Wootton SUMMARY: PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 61489 Parkway, Suite 600, Rockville, Maryland 20852, prior to close of business November 5, 2010. Dated: September 23, 2010. Garth N. Graham, Deputy Assistant Secretary for Minority Health, Office of Minority Health, Office of the Assistant Secretary for Health, Office of the Secretary, U.S. Department of Health and Human Services. [FR Doc. 2010–24880 Filed 10–4–10; 8:45 am] BILLING CODE 4150–29–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Renewal of Declaration Regarding Emergency Use of Doxycycline Hyclate Tablets Accompanied by Emergency Use Information AGENCY: Office of the Secretary (OS), HHS. ACTION: Notice. The Secretary of Homeland Security determined on September 23, 2008 that there is a significant potential for a domestic emergency involving a heightened risk of attack with a specified biological, chemical, radiological, or nuclear agent or agents—in this case, Bacillus anthracis. On the basis of this determination, the Secretary of Health and Human Services is renewing the October 1, 2008 declaration by former Secretary Michael O. Leavitt of an emergency justifying the authorization of emergency use of doxycycline hyclate tablets accompanied by emergency use information subject to the terms of any authorization issued by the Food and Drug Commissioner under 21 U.S.C. 360bbb–3(a). This notice is being issued in accordance with section 564(b)(4) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 360bbb–3(b)(4). DATES: This Notice and referenced HHS declaration are effective as of October 1, 2010. FOR FURTHER INFORMATION CONTACT: Nicole Lurie, MD MSPH, Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, 200 Independence Avenue, SW., Washington, DC 20201, Telephone (202) 205–2882 (this is not a toll free number). SUPPLEMENTARY INFORMATION: On September 23, 2008, former Secretary of Homeland Security, Michael Chertoff, determined that there is a significant potential for a domestic emergency, involving a heightened risk of attack SUMMARY: E:\FR\FM\05OCN1.SGM 05OCN1 61490 Federal Register / Vol. 75, No. 192 / Tuesday, October 5, 2010 / Notices with a specified biological, chemical, radiological, or nuclear agent or agents—in this case, Bacillus anthracis, although there is no current domestic emergency involving anthrax, no current heightened risk of an anthrax attack, and no credible information indicating an imminent threat of an attack involving Bacillus anthracis. Pursuant to section 564(b) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb–3(b), and on the basis of such determination, on October 1, 2008, former Secretary of Health and Human Services, Michael O. Leavitt, declared an emergency justifying the authorization of the emergency use of doxycycline hyclate tablets accompanied by emergency use information subject to the terms of any authorization issued under 21 U.S.C. 360bbb–3(a).1 Pursuant to section 564(b)(2)(B) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb– 3(b), and on the basis of Secretary Chertoff’s September 23, 2008 determination, I hereby renew former Secretary Leavitt’s October 1, 2008 declaration of an emergency, which I previously renewed on October 1, 2009, justifying the authorization of the emergency use of doxycycline hyclate tablets accompanied by emergency use information subject to the terms of any authorization issued under 21 U.S.C. 360bbb–3(a). I am issuing this notice in accordance with section 564(b)(4) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 360bbb–3(b)(4). Dated: September 24, 2010. Kathleen Sebelius, Secretary. [FR Doc. 2010–24840 Filed 9–30–10; 11:15 am] BILLING CODE 4150–37–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families OMB No.: 0970–0175. Description: Section 466(a)(5)(C) of the Social Security Act requires States to pass laws ensuring a simple civil process for voluntarily acknowledging paternity under which the State must provide that the mother and putative father must be given notice, orally and in writing, of the benefits and legal responsibilities and consequences of acknowledging paternity. The information is to be used by hospitals, birth record agencies, and other entities participating in the voluntary paternity establishment program that collect information from the parents of children that are born out of wedlock. Respondents: The parents of children that are born out of wedlock. Proposed Information Collection Activity; Comment Request Proposed Projects Title: Voluntary Establishment of Paternity—NPRM. ANNUAL BURDEN ESTIMATES Number of respondents Instrument Number of responses per respondent Average burden hours per response Total burden hours 1,167,097 1 0.17 198,406.49 Estimated Total Annual Burden Hours: .................................................... mstockstill on DSKH9S0YB1PROD with NOTICES None ................................................................................................................. ........................ ........................ ........................ 198,406.49 In compliance with the requirements of Section 506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L’Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail address: infocollection@acf.hhs.gov. All requests should be identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the 1 Pursuant to section 564(b)(4) of the FFDCA, notice of the determination by the Secretary, DHS, VerDate Mar<15>2010 18:36 Oct 04, 2010 Jkt 223001 agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: September 30, 2010. Robert Sargis, Reports Clearance Officer. AGENCY: [FR Doc. 2010–24893 Filed 10–4–10; 8:45 am] SUMMARY: Food and Drug Administration [Docket No. FDA–2010–N–0502] Agency Information Collection Activities; Proposed Collection; Comment Request; National Consumer Surveys on Understanding the Risks and Benefits of FDA-Regulated Medical Products Food and Drug Administration, HHS. ACTION: BILLING CODE 4184–01–P Notice. The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for and the declaration by the Secretary, HHS, was provided at 73 FR 58242 (October 6, 2008). PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 E:\FR\FM\05OCN1.SGM 05OCN1

Agencies

[Federal Register Volume 75, Number 192 (Tuesday, October 5, 2010)]
[Notices]
[Pages 61489-61490]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-24840]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Renewal of Declaration Regarding Emergency Use of Doxycycline 
Hyclate Tablets Accompanied by Emergency Use Information

AGENCY: Office of the Secretary (OS), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Secretary of Homeland Security determined on September 23, 
2008 that there is a significant potential for a domestic emergency 
involving a heightened risk of attack with a specified biological, 
chemical, radiological, or nuclear agent or agents--in this case, 
Bacillus anthracis. On the basis of this determination, the Secretary 
of Health and Human Services is renewing the October 1, 2008 
declaration by former Secretary Michael O. Leavitt of an emergency 
justifying the authorization of emergency use of doxycycline hyclate 
tablets accompanied by emergency use information subject to the terms 
of any authorization issued by the Food and Drug Commissioner under 21 
U.S.C. 360bbb-3(a). This notice is being issued in accordance with 
section 564(b)(4) of the Federal Food, Drug, and Cosmetic Act, 21 
U.S.C. 360bbb-3(b)(4).

DATES: This Notice and referenced HHS declaration are effective as of 
October 1, 2010.

FOR FURTHER INFORMATION CONTACT: Nicole Lurie, MD MSPH, Assistant 
Secretary for Preparedness and Response, Office of the Secretary, 
Department of Health and Human Services, 200 Independence Avenue, SW., 
Washington, DC 20201, Telephone (202) 205-2882 (this is not a toll free 
number).

SUPPLEMENTARY INFORMATION: On September 23, 2008, former Secretary of 
Homeland Security, Michael Chertoff, determined that there is a 
significant potential for a domestic emergency, involving a heightened 
risk of attack

[[Page 61490]]

with a specified biological, chemical, radiological, or nuclear agent 
or agents--in this case, Bacillus anthracis, although there is no 
current domestic emergency involving anthrax, no current heightened 
risk of an anthrax attack, and no credible information indicating an 
imminent threat of an attack involving Bacillus anthracis. Pursuant to 
section 564(b) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 
360bbb-3(b), and on the basis of such determination, on October 1, 
2008, former Secretary of Health and Human Services, Michael O. 
Leavitt, declared an emergency justifying the authorization of the 
emergency use of doxycycline hyclate tablets accompanied by emergency 
use information subject to the terms of any authorization issued under 
21 U.S.C. 360bbb-3(a).\1\ Pursuant to section 564(b)(2)(B) of the 
Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b), and on the 
basis of Secretary Chertoff's September 23, 2008 determination, I 
hereby renew former Secretary Leavitt's October 1, 2008 declaration of 
an emergency, which I previously renewed on October 1, 2009, justifying 
the authorization of the emergency use of doxycycline hyclate tablets 
accompanied by emergency use information subject to the terms of any 
authorization issued under 21 U.S.C. 360bbb-3(a). I am issuing this 
notice in accordance with section 564(b)(4) of the Federal Food, Drug, 
and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(4).
---------------------------------------------------------------------------

    \1\ Pursuant to section 564(b)(4) of the FFDCA, notice of the 
determination by the Secretary, DHS, and the declaration by the 
Secretary, HHS, was provided at 73 FR 58242 (October 6, 2008).

    Dated: September 24, 2010.
Kathleen Sebelius,
Secretary.
[FR Doc. 2010-24840 Filed 9-30-10; 11:15 am]
BILLING CODE 4150-37-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.